Numinus Wellness Inc.

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Sept. 10, 2020 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), is pleased to announce that it has closed its previously announced short form prospectus offering, on a best efforts basis, including the exercise o... Read More...

/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES/VANCOUVER, BC, Sept. 3, 2020 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted ther... Read More...

Advisors including Dr. Gabor Maté and Zach Walsh bring training and expertise in psychedelic-assisted therapy and mental health treatment VANCOUVER, BC , June 24, 2020 - Numinus Wellness Inc. ("Numinus") (NUMI.V) is pleased to announce its Clinical Advisory Council, chaired by Numinus Chief Medical Officer Dr. Evan Wood . Leveraging the e... Read More...

Numinus becomes first publicly traded company in Canada approved to conduct research of this kind under a Health Canada licence VANCOUVER, BC, June 11, 2020 - Numinus Wellness Inc. (TSX-V:NUMI) ("Numinus") has received Health Canada approval to amend the Company's existing Licence under the Controlled Drug and Substances Act to allow Numi... Read More...